Quick answer
What is Hexarelin?
Built from index records dated 2026-10-09 to 2026-10-13 Compiled by an automated pipeline, checked by The Peptide Observer editorial desk. No qualified clinical reviewer. How this site works
Hexarelin is a peptide, grouped on this site under Growth hormone secretagogues, and the 12 research records kept here are 8 from studies in rats or mice, 2 from trials in people and 2 that do not state what kind of study it is.
The literature search returned 327 records. This site keeps 12 of them, which is 3.7 per cent of what came back.
What it is
This site puts it in the Growth hormone secretagogues group.
A synthetic growth hormone secretagogue; the retrieved literature additionally reports cardiac effects described as growth hormone-independent.[1, 2]
Stated in the titles of the cited 2001 Journal of Clinical Endocrinology and Metabolism and 1999 Endocrinology papers.
What kind of records
A small number of the records kept here are trials in people.
That sentence is produced by counting, not by reading. What was counted: 2 interventional human trial records among 12 indexed records.
What this does not settle
- What it does in a body. Counting records is not reading them, and nothing here has been read in full.
- Whether it causes harm. No adverse-effect row was taken from any source for this entry.
- How long it lasts. No pharmacokinetics source was retrieved for this entry.
- What the other 315 retrieved records say. They are not in this index.
The longer explanation
Where this comes from
The records cited above, in full.
- Endocrine activities of ghrelin, a natural growth hormone secretagogue (GHS), in humans: comparison and interactions with hexarelin, a nonnatural peptidyl GHS, and GH-releasing hormone. J Clin Endocrinol Metab (2001). pmid:11238504
- Growth hormone-independent cardioprotective effects of hexarelin in the rat. Endocrinology (1999). pmid:10465272